Principal Investigator
Craig Moskowitz
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240391
Clinical Trial Summary
A phase 1, open-label study to evaluate SGN-35C in adults with advanced malignancies.
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Lymphoma
Contact Information
Phone Number
305-243-2647